Diplomat Pharmacy has agreed to acquire Focus Rx Pharmacy Services, a specialty and infusion pharmacy. "This partnership opens growth opportunities, especially in the key markets of New York and New Jersey," noted Phil Rielly, corporate vice president and president of Diplomat Specialty Infusion Group. "Focus Rx brings over 15 regional and national payor contracts, boosting Diplomat's prescription and payor access." Diplomat's specialty infusion services serve the needs of people living with chronic conditions such as alpha-1 antitrypsin deficiency, hemophilia, hereditary angioedema, immune deficiencies, nutritional deficiencies, and von Willebrand disease. The company noted that Focus Rx's nutrition deficiency business will complement ThriveRx, Diplomat's nutrition division. "As a specialty infusion provider in today's rapidly evolving health care environment, we are excited to partner with Diplomat to enhance the delivery of comprehensive and personalized services to our patients," said Lou Puleo, CEO of Focus Rx. “Our efforts improve patient results, as well as the clinical, operational and financial well-being of our partners." Financial terms of the deal were not disclosed.